This activity is intended for oncologists, dermatologists, pathologists, nurses, pharmacists, and other healthcare professionals involved in the care of patients with melanoma.
The goal of this activity is to discuss the evolving role for immunotherapy in the treatment of patients with melanoma.
Approximate Time to Complete: 30 minutes
Credit Available: Dec. 24, 2018 - Dec. 24, 2019
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have greater competence related to selecting the most appropriate regimen for patients with melanoma
- Have increased knowledge regarding the clinical trial data on the use of cancer immunotherapies in the management of melanoma
- Have greater competence related to collaborating with other members of the interprofessional team to produce optimal outcomes in the identification and management of immune-related adverse events